100percentfedup.com
House Committee Says Information Suggests Pfizer Executives Delayed COVID-19 Jab Testing To “Influence 2020 Election”
According to House Judiciary Committee Republicans, new information suggests Pfizer executives “conspired to delay COVID-19 vaccine clinical testing” to influence the 2020 election.
“One exec was so scared about this being investigated that he asked to be relocated to Canada!” House Judiciary GOP stated.
HUGE
New Information Suggests Senior Pfizer Executives Conspired to Delay COVID-19 Vaccine Clinical Testing to Influence 2020 Election.
One exec was so scared about this being investigated that he asked to be relocated to Canada!
MASSIVE SCANDAL uncovered by @Jim_Jordan. pic.twitter.com/pZKLAz1Wmx
— House Judiciary GOP (@JudiciaryGOP) May 15, 2025
A closer look:
“House Judiciary Committee Chairman Jim Jordan (R-OH) sent letters to the Chairman and CEO of Pfizer, Dr. Albert Bourla, and Pfizer’s former Global Head of Vaccines Research and Development, Dr. Philip Dormitzer, after new information appears to suggest that senior Pfizer executives conspired to withhold data about Pfizer’s COVID-19 vaccine to influence the 2020 presidential election,” House Judiciary Republicans stated in a press release.
“Did Pfizer executives conspire to delay COVID-19 vaccine testing to influence the 2020 election? Based on our oversight, it sure looks like it,” Rep. Jim Jordan (R-OH) said.
Did Pfizer executives conspire to delay COVID-19 vaccine testing to influence the 2020 election?
Based on our oversight, it sure looks like it. https://t.co/VUCDlDDGiu
— Rep. Jim Jordan (@Jim_Jordan) May 15, 2025
Cont. from the press release:
On March 26, 2025, the Wall Street Journal reported that authorities were in possession of information that originated from a former senior Pfizer executive related to whether Pfizer “sat on the positive results of clinical trials” of its COVID-19 vaccine so as to influence the 2020 presidential election. The Journal identified Dr. Philip Dormitzer as the former Pfizer executive, and reported that he disclosed this information to his then-current employer, GSK plc, in “late 2024” following President Trump’s election.
On April 9, 2025, the Committee wrote to GSK requesting additional information about these allegations. GSK responded on April 16, 2025. In its letter to the Committee, GSK stated:
“In November 2024, shortly after the election, Dr. Dormitzer approached a representative from the GSK human resources team to speak about a potential relocation abroad. As the human resources representative recalls, in their meeting, Dr. Dormitzer was visibly upset; he requested that he be relocated to Canada due to concerns that he could be investigated by the incoming Trump Administration over his role in developing Pfizer’s COVID-19 vaccine. According to the human resources representative, when asked what prompted his request, Dr. Dormitzer made a comment to the effect of: ‘Let’s just say it wasn’t a coincidence, the timing of the vaccine.'”
GSK further informed the Committee that Dr. Dormitzer had told GSK employees that “in late 2020, the three most senior people in Pfizer R&D were involved in a decision to deliberately slow down clinical testing so that it would not be complete prior to the results of the presidential election that year.”
JUST IN: The House GOP is now investigating an alleged conspiracy by Pfizer executives to DELAY COVID vaccine clinical testing to alter the results of the 2020 election.
"…were involved in a decision to deliberately slow down clinical testing so that it would not be… pic.twitter.com/zyURvW4hQs
— Eric Daugherty (@EricLDaugh) May 15, 2025
A closer look:
Per Fierce Pharma:
Shortly after President Donald Trump won his second presidential election in the U.S. last fall, British drugmaker GSK came to federal prosecutors in New York, bearing intel from employees’ conversations that rival Pfizer allegedly delayed the 2020 release of its COVID shot study results, the Wall Street Journal reported Wednesday, citing people familiar with the matter.
The tip comes from GSK employees who worked with Philip Dormitzer, M.D., Ph.D., a Pfizer-turned-GSK scientist who headed up vaccine R&D and infectious disease research at GSK for three years before leaving the company in late 2024. Before that, Dormitzer spent six years at Pfizer, where he “had a leadership role” in the development of COVID vaccine Comirnaty as chief scientific officer for RNA and viral vaccines, according to his LinkedIn.
The U.S. attorney’s office in Manhattan has already interviewed at least two people in connection to the tip, including a GSK executive who took notes on a conversation with Dormitzer, one person familiar with the matter told WSJ. The prosecutors reportedly haven’t yet spoken with Pfizer officials in the investigation.